EKF Diagnostics (LON:EKF) Shares Climb 0.4% – Should You Buy?

EKF Diagnostics Holdings plc (LON:EKF)’s stock price rose 0.4% during mid-day trading on Wednesday. The company traded as high as GBX 24.64 and last traded at GBX 24.50. Approximately 108,105 shares were traded during trading, a decline of 69% from the average session volume of 343,814 shares. The stock had previously closed at GBX 24.40.

EKF Diagnostics Price Performance

The business has a 50-day simple moving average of GBX 24.76 and a 200 day simple moving average of GBX 25.31. The firm has a market cap of £102.71 million, a P/E ratio of 41.38 and a beta of 0.51. The company has a debt-to-equity ratio of 2.09, a quick ratio of 1.77 and a current ratio of 4.72.

EKF Diagnostics (LON:EKF) last released its quarterly earnings data on Tuesday, September 15th. The company reported GBX 0.54 earnings per share for the quarter. EKF Diagnostics had a return on equity of 3.58% and a net margin of 4.86%. On average, analysts anticipate that EKF Diagnostics Holdings plc will post 2.30 earnings per share for the current fiscal year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.